NEWS RELEASE

For more information, contact:


Steve Albright                                           or:               Fred Nielson
Chief Financial Officer                                                   Investor Relations
(636) 733-1305                                                          (636) 733-1314

 

FOR IMMEDIATE DISTRIBUTION

 

Reliv International Reports Fourth-Quarter
and Full-Year Financial Results for 2012

 

CHESTERFIELD, Missouri, March 6, 2013 – Reliv International, Inc. (NASDAQ:RELV), a maker of nutritional supplements that promote optimal health, today reported its financial results for the fourth quarter and full year of 2012.

 

Fourth-Quarter Results
Reliv reported net sales of $16.91 million for the fourth quarter of 2012, compared with sales of $16.89 million for the fourth quarter of 2011, an increase of 0.1 percent. U.S. sales declined by 3.2 percent for the quarter compared with the same quarter in 2011. International sales for the quarter increased 13.1 percent, led by significant growth in Europe, which reported an increase of 49.5 percent.

 

Reliv reported net income of $437,000, or $0.03 per diluted share, for the fourth quarter of 2012 compared with net income of $320,000, or $0.03 per diluted share, for the fourth quarter of 2011. Income from operations for the fourth quarter of 2012 was $611,000 compared with $471,000 in the same quarter of 2011.

 

Full-Year Results
Reliv reported net sales of $68.71 million for 2012 compared with net sales of $73.88 million in 2011. U.S. net sales decreased from $60.88 million to $53.80 million. Net sales in Reliv’s foreign markets for 2012 increased 14.7 percent compared with net sales for 2011. Net sales were particularly strong in Europe, where net sales increased by $2.73 million, or 72.7 percent. Growth in the European market in 2012 was driven by strong increases in new distributor enrollments and new Master Affiliate qualifications, along with the launch of Reliv NOW® with LunaRich® in October 2012.

 

Net income for 2012 was $1.36 million compared with $1.05 million in 2011. Diluted earnings per share were $0.11 in 2012 compared with $0.08 in 2011.

 

“The net sales increase in the fourth quarter of 2012 compared with the fourth quarter of 2011 marks the first quarterly year-over-year net sales increase in more than five years at Reliv,” said Robert L. Montgomery, chairman and chief executive officer of Reliv. “We believe that with continuing growth in Europe and initiatives underway worldwide it is the first of many to come.”

 

“Reliv Europe has recorded 13 straight quarters of year-over-year growth and continues to show strong momentum,” he added. “When compared to the previous year, the number of distributors in Europe increased 79.7 percent in 2012 after climbing 77.4 percent in 2011. We expect to officially open in France in the spring of 2013, our 16th country of operation. We expect France to provide continued opportunities, momentum and improved economies of scale.”

“In the United States, Reliv expanded its exclusive LunaRich product line with the January 2013 introduction of LunaRich X™ (concentrated lunasin in capsule form). We also launched a new points-based LunaRich wellness system, which is an easy-to-understand way for our distributors to share LunaRich products and for customers to design their own LunaRich regimen. We believe this system, the first of its kind at Reliv, will help make the leading-edge science of lunasin easier to understand and make our LunaRich products easier to use,” Montgomery said.

 

“In coordination with our public relations agency, we developed an aggressive campaign to build awareness of lunasin and LunaRich,” he added. “LunaRich products have appeared on local TV and in newspapers across the country, and we now are targeting national mainstream media. We believe such exposure will lead to increased demand for our products.”

 

“On March 1, 2013, we implemented a new pricing structure. As the result of higher commodity and ingredient costs, we increased prices — our first in more than four years — however, we also increased servings per unit and cut shipping fees. The resulting price per serving is only pennies higher for most products, and we believe the reduced shipping will help eliminate a common point-of-sale objection,” Montgomery said.

 

“Our strategic objective to simplify our business and increase efficiency continues to produce results,” he added. Reliv reported a reduction in selling, general and administrative expenses of $175,000 for the fourth quarter of 2012 and $1.93 million for all of 2012 compared with the prior-year periods. Reliv had cash and cash equivalents of $5.80 million as of December 31, 2012, a decrease of $1.37 million from the balance as of December 31, 2011. Net cash generated from operating activities decreased to $2.47 million in 2012 from $2.79 million in 2011.

 

As of December 31, 2012, Reliv had 57,430 distributors – an increase of 0.7 percent from December 31, 2011 – of which 7,060 are Master Affiliate level and above. Master Affiliate is the level at which distributors are eligible to earn generation royalties.

 

About Reliv International, Inc.
Reliv International, Inc., based in Chesterfield, Missouri, produces nutritional supplements that promote optimal nutrition along with premium skincare products. Reliv supplements address essential nutrition, weight loss, athletic performance, digestive health, women's health, anti-aging and healthy energy. The company sells its products through an international network marketing system of independent distributors in 15 countries. Learn more about Reliv at www.reliv.com, or on Facebook, Twitter or YouTube.
Statements made in this news release that are not historical facts are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995) that involve risks and uncertainties and are subject to change at any time. These forward-looking statements may include, but are not limited to, statements containing words such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue” or similar expressions. Factors that could cause actual results to differ are identified in the public filings made by Reliv with the Securities and Exchange Commission. More information on factors that could affect Reliv’s business and financial results are included in its public filings made with the Securities and Exchange Commission, including its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, copies of which are available on the Company’s web site, www.reliv.com.

 

--FINANCIAL HIGHLIGHTS FOLLOW –

 

Financial Highlights

 

 

 

 

thirty-day.png

 

 

Copyright 2017 Reliv International. All rights reserved.
136 Chesterfield Ind. Blvd., Chesterfield, MO 63005
Toll free: 800.735.4887
Phone 636.733.1300 | Fax 636.537.9753
Contact Us  |  Privacy Policy  |  Investor Relations